There is one clinical trial.
This proposed study will assess how COVID-19 and the associated 'stay at home' orders are affecting low-income Rwandan couples' relationships and family dynamics. The study builds on an existing randomized controlled trial of the Bandebereho fathers/couples intervention (NCT02694627), which will allow us to assess not only the current conditions in households, but also whether or how the significant impacts of the intervention are sustained under extreme stress.
Description: Question about how caregiving is distributed in the wake of Covid-19Measure: Gender division of caregiving/domestic tasks Time: ~5 years post intervention
Description: Frequency of couple communication in the wake of Covid-19Measure: Couple communication Time: ~5 years post intervention
Description: Frequency of couple quarreling in the wake of Covid-19Measure: Couple conflict Time: ~5 years post intervention
Description: Frequency of men's alcohol use in the wake of Covid-19Measure: Men's alcohol use Time: ~5 years post intervention
Description: Changes in household economic situation in the wake of Covid-19Measure: Household economic situation Time: ~5 years post intervention
Description: Feelings of stress and frustration in the wake of Covid-19Measure: Stress and frustration Time: ~5 years post intervention
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports